Literature DB >> 28278448

Screening for anxiety, depression, and anxious depression in primary care: A field study for ICD-11 PHC.

David P Goldberg1, Geoffrey M Reed2, Rebeca Robles3, Fareed Minhas4, Bushra Razzaque4, Sandra Fortes5, Jair de Jesus Mari6, Tai Pong Lam7, José Ángel Garcia3, Linda Gask8, Anthony C Dowell9, Marianne Rosendal10, Joseph K Mbatia11, Shekhar Saxena12.   

Abstract

BACKGROUND: In this field study of WHO's revised classification of mental disorders for primary care settings, the ICD-11 PHC, we tested the usefulness of two five-item screening scales for anxiety and depression to be administered in primary care settings.
METHODS: The study was conducted in primary care settings in four large middle-income countries. Primary care physicians (PCPs) referred individuals who they suspected might be psychologically distressed to the study. Screening scales as well as a structured diagnostic interview, the revised Clinical Interview Schedule (CIS-R), adapted for proposed decision rules in ICD-11 PHC, were administered to 1488 participants.
RESULTS: A score of 3 or more on one or both screening scale predicted 89.6% of above-threshold mood or anxiety disorder diagnoses on the CIS-R. Anxious depression was the most common CIS-R diagnosis among referred patients. However, there was an exact diagnostic match between the screening scales and the CIS-R in only 62.9% of those with high scores. LIMITATIONS: This study was confined to those in whom the PCP suspected psychological distress, so does not provide information about the prevalence of mental disorders in primary care settings.
CONCLUSIONS: The two five-item screening scales for anxiety and depression provide a practical way for PCPs to evaluate the likelihood of mood and anxiety disorders without paper and pencil measures that are not feasible in many settings. These scales may provide substantially improved case detection as compared to current primary care practice and a realistic alternative to complex diagnostic algorithms used by specialist mental health professionals.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Anxiety; Depression; ICD-11; Primary care; Screening

Mesh:

Year:  2017        PMID: 28278448     DOI: 10.1016/j.jad.2017.02.025

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Are official psychiatric classification systems for mental disorders suitable for use in primary care?

Authors:  Sir David Goldberg
Journal:  Br J Gen Pract       Date:  2019-03       Impact factor: 5.386

Review 2.  Using Artificial Intelligence to Enhance Ongoing Psychological Interventions for Emotional Problems in Real- or Close to Real-Time: A Systematic Review.

Authors:  Patricia Gual-Montolio; Irene Jaén; Verónica Martínez-Borba; Diana Castilla; Carlos Suso-Ribera
Journal:  Int J Environ Res Public Health       Date:  2022-06-24       Impact factor: 4.614

3.  Screening Tool for Mental Health Problems During COVID-19 Pandemic: Psychometrics and Associations With Sex, Grieving, Contagion, and Seeking Psychological Care.

Authors:  Silvia Morales Chainé; Rebeca Robles García; Alejandra López Montoya; Alejandro Bosch Maldonado; Ana Gisela Beristain Aguirre; Claudia Lydia Treviño Santa Cruz; Germán Palafox Palafox; Isaura Angélica Lira Chávez; Lydia Barragán Torres; María Gudelia Rangel Gómez
Journal:  Front Psychol       Date:  2022-06-10

4.  HiTOP must meet the use requirements of the ICD before it can aspire to replace it.

Authors:  Geoffrey M Reed
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

5.  A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries.

Authors:  Anisa Y Mughal; Jackson Devadas; Eric Ardman; Brooke Levis; Vivian F Go; Bradley N Gaynes
Journal:  BMC Psychiatry       Date:  2020-06-30       Impact factor: 3.630

6.  Studying ICD-11 Primary Health Care bodily stress syndrome in Brazil: do many functional disorders represent just one syndrome?

Authors:  Sandra Fortes; Carolina Ziebold; Geoffrey M Reed; Rebeca Robles-Garcia; Monica R Campos; Emilene Reisdorfer; Ricardo Prado; David Goldberg; Linda Gask; Jair J Mari
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

7.  Mental Health Problems among COVID-19 Frontline Healthcare Workers and the Other Country-Level Epidemics: The Case of Mexico.

Authors:  Rebeca Robles; Silvia Morales-Chainé; Alejandro Bosch; Claudia Astudillo-García; Miriam Feria; Sara Infante; Natasha Alcocer-Castillejos; Leticia Ascencio; Janet Real-Ramírez; Dulce Díaz; Héctor Francisco Gómez-Estrada; Claudia Becerra; Raúl Escamilla; Alejandra López-Montoya; Ana Beristain-Aguirre; Hamid Vega; Dení Álvarez-Icaza; Evelyn Rodríguez; Sol Durand; Ana Fresán; María-Elena Medina-Mora; Carmen Fernández-Cáceres; Eduardo Ángel Madrigal de León
Journal:  Int J Environ Res Public Health       Date:  2021-12-31       Impact factor: 3.390

8.  Brief Screening for Distress among Healthcare Professionals: Psychometric Properties of the Physician Well-Being Index-Spanish Version.

Authors:  Rebeca Robles; Ana Fresán; Natasha Alcocer-Castillejos; Janet Real-Ramírez; Silvia Morales-Chainé
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

9.  Dimensional analysis of depressive, anxious and somatic symptoms presented by primary care patients and their relationship with ICD-11 PHC proposed diagnoses.

Authors:  Carolina Ziebold; David P Goldberg; Geoffrey M Reed; Fareed Minhas; Bushra Razzaque; Sandra Fortes; Rebeca Robles; Tai Pong Lam; Julio Bobes; Celso Iglesias; Hugo Cogo-Moreira; José Ángel García; Jair J Mari
Journal:  Psychol Med       Date:  2018-06-04       Impact factor: 7.723

10.  Factors Differentiating Rural and Urban Population in Determining Anxiety and Depression in Patients with Chronic Cardiovascular Disease: A Pilot Study.

Authors:  Elżbieta Szlenk-Czyczerska; Marika Guzek; Dorota Emilia Bielska; Anna Ławnik; Piotr Polański; Donata Kurpas
Journal:  Int J Environ Res Public Health       Date:  2021-03-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.